Jenburkt Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1200.00

-1.05 (-0.09%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

1200.00

-1.05 (-0.09%)
15:28 Dec 27

Quality

70/100
High Financial Strength

Valuation

47/100
Mid Valuation

Technical

60/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	109.29	123.98	136.75	141.97	148.26
Operating Expenses +	89.45	96.73	106.38	108.85	110.49
Raw Material	26.91	33.72	31.67	30.8	29.82
Increase Decrease in Cost	3.18	-2.28	1.34	-0.39	0.41
Other Manufacturing Expense	0.34	0.63	0.8	0.73	0
Employee Cost	32.38	36.49	38.81	42.49	45.13
Miscellaneous Expenses	66.9	72.13	74.86	80.04	35.13
Operating Profit	19.84	27.25	30.37	33.12	37.77
Other Income	4.31	4.95	5.12	4.67	5.8
Depreciation	2.04	1.9	2.26	2.34	2.41
Interest	0.47	0.43	0.37	0.27	0.36
Profit before tax and exceptio..	21.64	29.87	32.86	35.18	40.8
Exceptional Items	0	0	0	0	0
PBT	21.64	29.87	32.86	35.18	40.8
Provision for Taxation	5.14	7.57	8.26	9.2	10.49
Net Profit	16.5	22.3	24.61	25.98	30.3
NET Profit after MI	0	0	0	0	0
EPS	35.96	48.58	53.9	58.86	68.66
Operating Profit Margin (%)	18.15	21.98	22.21	23.33	25.48
Net Profit Margin (%)	15.1	17.99	18	18.3	20.44

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	46.70	46.70	47.20	47.40	47.40
FII	0.00	0.00	0.00	0.00	1.40
MF	0.00	0.00	0.00	0.00	0.00
Public	53.30	53.30	52.80	52.60	51.20
Others	0.00	0.00	0.00	0.00	0.00
Others	0.00	0.00	0.00	0.00	0.00